FI104465B
(fi)
*
|
1995-06-14 |
2000-02-15 |
Valio Oy |
Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
|
EP0986314B1
(en)
*
|
1997-06-03 |
2008-09-10 |
Ganeden Biotech, Inc. |
Probiotic lactic acid bacterium to treat bacterial infections associated with sids
|
AU3210200A
(en)
|
1999-01-19 |
2000-08-01 |
Maxygen, Inc. |
Oligonucleotide mediated nucleic acid recombination
|
AU6160200A
(en)
|
1999-08-05 |
2001-03-05 |
Societe Des Produits Nestle S.A. |
New bifidobacteria preventing diarrhea caused by pathogenic bacteria
|
WO2001010453A2
(en)
|
1999-08-05 |
2001-02-15 |
Societe Des Produits Nestle S.A. |
Bifidobacteria capable of preventing diarrhea
|
US20020031787A1
(en)
*
|
2000-02-04 |
2002-03-14 |
Maclaren Noel K. |
Compositions and methods for reducing autoimmunity
|
FI110668B
(fi)
|
2000-06-20 |
2003-03-14 |
Aboatech Ab Oy |
Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
|
PL365246A1
(en)
|
2000-09-25 |
2004-12-27 |
Societe Des Produits Nestle S.A. |
Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
|
JP4510376B2
(ja)
|
2000-10-06 |
2010-07-21 |
ソシエテ・デ・プロデュイ・ネスレ・エス・アー |
皮膚の免疫系のバランスを保つためのプロバイオティック乳酸菌の使用
|
FI109602B
(fi)
*
|
2001-01-25 |
2002-09-13 |
Valio Oy |
Probioottiyhdistelmä
|
EP1228707A1
(en)
*
|
2001-02-01 |
2002-08-07 |
Campina Melkunie B.V. |
Use of alpha-lactalbumin as prebiotic agent
|
EP1372412A2
(en)
*
|
2001-03-09 |
2004-01-02 |
Societe Des Produits Nestle S.A. |
Composition improving age-related physiological deficits and increasing longevity
|
JP2003137804A
(ja)
*
|
2001-10-31 |
2003-05-14 |
Morinaga Milk Ind Co Ltd |
インターロイキン−18誘導剤
|
EP1364586A1
(en)
*
|
2002-05-24 |
2003-11-26 |
Nestec S.A. |
Probiotics and oral tolerance
|
EP1509609B1
(en)
|
2002-06-04 |
2015-04-22 |
DSM IP Assets B.V. |
Protein hydrolysate rich in tripeptides
|
DK1565547T4
(da)
|
2002-06-28 |
2013-01-14 |
Biosearch S A |
Probiotiske stammer, en fremgangsmåde til selektion deraf, præparater deraf samt anvendelse deraf
|
EP1384483A1
(en)
|
2002-07-23 |
2004-01-28 |
Nestec S.A. |
Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
|
US7105336B2
(en)
*
|
2002-10-07 |
2006-09-12 |
Biogaia Ab |
Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
|
US20040208863A1
(en)
*
|
2003-01-30 |
2004-10-21 |
James Versalovic |
Anti-inflammatory activity from lactic acid bacteria
|
CA2530437C
(en)
*
|
2003-06-23 |
2011-11-15 |
Nestec S.A. |
Nutritional formula for optimal gut barrier function
|
CA2556736C
(en)
|
2004-02-25 |
2013-02-19 |
Pioneer Hi-Bred International, Inc. |
Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
|
US20050265946A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Kao Corporation |
Elastase inhibitor
|
US7862808B2
(en)
*
|
2004-07-01 |
2011-01-04 |
Mead Johnson Nutrition Company |
Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
|
CA2604338A1
(en)
|
2005-04-13 |
2006-10-19 |
Nestec S.A. |
Infant formula with probiotics
|
US7303745B2
(en)
*
|
2005-04-15 |
2007-12-04 |
Bristol-Myers Squibb Company |
Method for preventing or treating the development of respiratory allergies
|
US20060233762A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Mcmahon Robert J |
Method for treating or preventing systemic inflammation in formula-fed infants
|
WO2007054587A1
(en)
*
|
2005-11-14 |
2007-05-18 |
Nestec S.A. |
Oral tolerance promotion with glycated proteins
|
CN101420965B
(zh)
|
2006-02-15 |
2013-08-07 |
雀巢产品技术援助有限公司 |
长双歧杆菌在制备预防和治疗炎症的药物中的用途
|
CN101432007A
(zh)
|
2006-03-07 |
2009-05-13 |
雀巢产品技术援助有限公司 |
合益素混合物
|
AU2007259231B2
(en)
*
|
2006-06-15 |
2013-05-09 |
Nestec S.A. |
Induction of tolerance to egg proteins
|
EP2124977B9
(en)
*
|
2007-02-28 |
2012-05-02 |
Mead Johnson Nutrition Company |
Method for treating or preventing systemic inflammation
|
EP1974734A1
(en)
†
|
2007-03-28 |
2008-10-01 |
Nestec S.A. |
Probiotics for reduction of risk of obesity
|
CN101273736B
(zh)
*
|
2007-03-28 |
2012-08-08 |
北京弗蒙特生物技术有限公司 |
一种在常温下保持高活菌数的发酵乳的制备方法
|
EP1974743A1
(en)
|
2007-03-28 |
2008-10-01 |
Nestec S.A. |
Probiotics to Improve Gut Microbiota
|
EP1974735A1
(en)
|
2007-03-28 |
2008-10-01 |
Nestec S.A. |
Reduction of risk of diarrhoea
|
WO2009029554A2
(en)
|
2007-08-24 |
2009-03-05 |
Codexis, Inc. |
Improved ketoreductase polypeptides for the stereoselective production of (r)-3-hydroxythiolane
|
EP2072052A1
(en)
|
2007-12-17 |
2009-06-24 |
Nestec S.A. |
Prevention of opportunistic infections in immune-compromised subjects
|
JP2011509677A
(ja)
|
2008-01-24 |
2011-03-31 |
ネステク ソシエテ アノニム |
栄養原料を含むカプセル、及び、カプセルから栄養液体を送出する方法
|
DK2244734T3
(en)
|
2008-02-01 |
2016-08-15 |
Murdoch Childrens Res Inst |
PROCEDURE FOR INDUCTION OF TOLERANCE ABOUT AN ALLERGY
|
UA100551C2
(en)
|
2008-03-14 |
2013-01-10 |
Нестек С.А. |
Synbiotic mixture
|
EP2127661A1
(en)
|
2008-05-27 |
2009-12-02 |
Nestec S.A. |
Probiotics to improve gut microbiotica
|
US20090312196A1
(en)
|
2008-06-13 |
2009-12-17 |
Codexis, Inc. |
Method of synthesizing polynucleotide variants
|
WO2009152336A1
(en)
|
2008-06-13 |
2009-12-17 |
Codexis, Inc. |
Method of synthesizing polynucleotide variants
|
ES2438576T3
(es)
|
2008-06-24 |
2014-01-17 |
Codexis, Inc. |
Procesos biocatalíticos para la preparación de compuestos de prolina bicíclica fusionada considerablemente pura estereoméricamente
|
EP2147678A1
(en)
|
2008-07-21 |
2010-01-27 |
Nestec S.A. |
Probiotics to increase IgA secretion in infants born by caesarean section
|
US8426178B2
(en)
|
2008-08-27 |
2013-04-23 |
Codexis, Inc. |
Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
|
CN102341494B
(zh)
|
2009-01-08 |
2014-10-15 |
科德克希思公司 |
转氨酶多肽
|
BRPI1013886A2
(pt)
|
2009-03-17 |
2016-10-11 |
Codexis Inc |
variantes de endoglucanases, polinucleotídeos e usos a elas relacionados
|
EP2414506B1
(en)
|
2009-03-31 |
2017-05-03 |
Codexis, Inc. |
Improved endoglucanases
|
US8357523B2
(en)
|
2009-06-16 |
2013-01-22 |
Codexis, Inc. |
Beta-glucosidase variant enzymes and related polynucleotides
|
WO2011005527A2
(en)
|
2009-06-22 |
2011-01-13 |
Codexis, Inc. |
Ketoreductase-mediated stereoselective route to alpha chloroalcohols
|
US8614081B2
(en)
|
2009-07-23 |
2013-12-24 |
Codexis, Inc. |
Nitrilase biocatalysts
|
MX2012002039A
(es)
*
|
2009-08-18 |
2012-04-11 |
Nestec Sa |
Una composicion nutricional que comprende cepas de lactococcus y que reduce los sintomas de la alergia, especialmente en infantes y en niños.
|
ES2664724T3
(es)
|
2009-08-18 |
2018-04-23 |
Nestec S.A. |
Composición nutricional que comprende cepas de Bifidobacterium longum y que reduce los síntomas de alergia alimentaria, especialmente en lactantes y niños
|
EP2467473B1
(en)
|
2009-08-19 |
2016-03-23 |
Codexis, Inc. |
Ketoreductase polypeptides for the preparation of phenylephrine
|
EP2473604B1
(en)
|
2009-09-04 |
2017-01-11 |
Codexis, Inc. |
Variant cbh2 cellulases and related polynucleotides
|
EP2295535A1
(en)
*
|
2009-09-11 |
2011-03-16 |
Mead Johnson Nutrition Company |
Probiotic material
|
HUE051913T2
(hu)
|
2009-09-18 |
2021-04-28 |
Codexis Inc |
Csökkentett kodon mutagenezis
|
MX355841B
(es)
|
2009-11-25 |
2018-05-02 |
Codexis Inc |
Variantes de beta-glucosidasa recombinante para producción de azúcares solubles de biomasa celulósica.
|
CA2781399C
(en)
|
2009-11-25 |
2015-01-20 |
Codexis, Inc. |
Recombinant thermoascus aurantiacus beta-glucosidase variants for production of fermentable sugars from cellulosic biomass
|
EP2510089B1
(en)
|
2009-12-08 |
2015-10-21 |
Codexis, Inc. |
Synthesis of prazole compounds
|
RU2563355C2
(ru)
|
2009-12-08 |
2015-09-20 |
Нестек С.А. |
Смесь для грудных детей с пробиотиками и компонентами оболочек жировых шариков молока
|
MX2012007681A
(es)
|
2009-12-31 |
2013-01-29 |
Pioneer Hi Bred Int |
Ingenieria de resistencia de plantas a enfermedades causadas por patogenos.
|
WO2011140219A1
(en)
|
2010-05-04 |
2011-11-10 |
Codexis, Inc. |
Biocatalysts for ezetimibe synthesis
|
WO2011143274A1
(en)
|
2010-05-10 |
2011-11-17 |
Perseid Therapeutics |
Polypeptide inhibitors of vla4
|
WO2011150313A1
(en)
|
2010-05-28 |
2011-12-01 |
Codexis, Inc. |
Pentose fermentation by a recombinant microorganism
|
HUE038434T2
(hu)
|
2010-06-17 |
2018-10-29 |
Codexis Inc |
Biokatalizátorok és módszerek (S)-3(1-aminoetil)-fenol szintéziséhez
|
EP2585587B1
(en)
|
2010-06-28 |
2017-08-09 |
Codexis, Inc. |
Fatty alcohol forming acyl reductases (fars) and methods of use thereof
|
WO2012003299A2
(en)
|
2010-06-30 |
2012-01-05 |
Codexis, Inc. |
Highly stable beta-class carbonic anhydrases useful in carbon capture systems
|
WO2012024100A2
(en)
|
2010-08-16 |
2012-02-23 |
Merck Sharp & Dohme Corp. |
Process for preparing aminocyclohexyl ether compounds
|
WO2012024698A1
(en)
|
2010-08-20 |
2012-02-23 |
Codexis, Inc. |
Use of glycoside hydrolase 61 family proteins in processing of cellulose
|
EP2649187B1
(en)
|
2010-12-08 |
2017-11-22 |
Codexis, Inc. |
Biocatalysts and methods for the synthesis of armodafinil
|
EE05721B1
(et)
|
2011-02-25 |
2014-08-15 |
OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus |
Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine
|
EP2691517A4
(en)
|
2011-03-30 |
2015-04-22 |
Codexis Inc |
FERMENTATION OF PENTOSES BY A RECOMBINANT MICROORGANISM
|
DK2697662T3
(en)
|
2011-04-13 |
2018-07-30 |
Codexis Inc |
BIOCATALYTIC PROCEDURE FOR PREPARING ESLICARBAZEPIN AND ANALOGUES THEREOF
|
UA111078C2
(uk)
*
|
2011-05-03 |
2016-03-25 |
Нестек С.А. |
Гідролізат білкового субстрату і спосіб його виготовлення
|
BR112013033614A2
(pt)
|
2011-06-30 |
2018-05-29 |
Codexis Inc |
fermentação de pentose por microorganismo recombinante
|
DK2748317T3
(en)
|
2011-08-22 |
2017-07-17 |
Codexis Inc |
GH61 glycoside hydrolase protein variants and cofactors that enhance GH61 activity
|
EP2753640B1
(en)
|
2011-09-08 |
2016-03-09 |
Codexis, Inc. |
Biocatalysts and methods for the synthesis of substituted lactams
|
US20130084608A1
(en)
|
2011-09-30 |
2013-04-04 |
Codexis, Inc. |
Fungal proteases
|
US20130084271A1
(en)
*
|
2011-10-03 |
2013-04-04 |
Kelly Foods Corporation |
Probiotic composition for pets and method of providing the same
|
US20130089638A1
(en)
*
|
2011-10-11 |
2013-04-11 |
Mead Johnson Nutrition Company |
Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
|
US9139819B2
(en)
|
2011-11-18 |
2015-09-22 |
Codexis, Inc. |
Biocatalysts for the preparation of hydroxy substituted carbamates
|
WO2013096244A1
(en)
|
2011-12-20 |
2013-06-27 |
Codexis, Inc. |
Endoglucanase 1b (eg1b) variants
|
EP2828385B1
(en)
|
2012-03-23 |
2018-02-07 |
Codexis, Inc. |
Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
|
US20130251829A1
(en)
*
|
2012-03-23 |
2013-09-26 |
Mead Johnson Nutrition Company |
Probiotic derived non-viable material for infection prevention and treatment
|
SG11201407295YA
(en)
|
2012-05-08 |
2014-12-30 |
Codexis Inc |
Biocatalysts and methods for hydroxylation of chemical compounds
|
CN107904216B
(zh)
|
2012-05-11 |
2021-06-29 |
科德克希思公司 |
工程化亚胺还原酶以及用于酮和胺化合物的还原胺化的方法
|
BR112014031026A2
(pt)
|
2012-06-11 |
2017-06-27 |
Codexis Inc |
variantes de beta-xilosidase fúngica.
|
EP2922953A4
(en)
|
2012-11-20 |
2016-11-09 |
Shell Int Research |
FERMENTATION OF PENTOSIS BY A RECOMBINANT MICROORGANISM
|
WO2014088984A1
(en)
|
2012-12-07 |
2014-06-12 |
Merck Sharp & Dohme Corp. |
Biocatalytic transamination process
|
HUE051359T2
(hu)
|
2012-12-21 |
2021-03-01 |
Codexis Inc |
Génmódosított biokatalizátorok és eljárások királis aminok szintetizálására
|
CN105051180B
(zh)
|
2013-01-18 |
2020-06-12 |
科德克希思公司 |
用于碳青霉烯类合成的工程化的生物催化剂
|
CN115927231A
(zh)
|
2013-02-28 |
2023-04-07 |
科德克希思公司 |
用于工业生物催化的工程化转氨酶多肽
|
CN103355405A
(zh)
*
|
2013-04-07 |
2013-10-23 |
苏州旭优食品科技有限公司 |
一种低过敏性含乳制品的加工工艺
|
KR102218930B1
(ko)
|
2013-04-18 |
2021-02-23 |
코덱시스, 인코포레이티드 |
조작된 페닐알라닌 암모니아 리아제 폴리펩티드
|
EP3068793B1
(en)
|
2013-11-13 |
2021-02-17 |
Codexis, Inc. |
Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
|
US9605252B2
(en)
|
2014-04-16 |
2017-03-28 |
Codexis, Inc. |
Engineered tyrosine ammonia lyase
|
DK3167052T3
(da)
|
2014-07-09 |
2020-02-10 |
Codexis Inc |
P450-bm3-varianter med forbedret aktivitet
|
US10370648B2
(en)
|
2014-11-25 |
2019-08-06 |
Codexis, Inc. |
Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
CA2970638A1
(en)
|
2014-12-22 |
2016-06-30 |
Codexis, Inc. |
Human alpha-galactosidase variants
|
ES2830725T3
(es)
|
2015-02-10 |
2021-06-04 |
Codexis Inc |
Polipéptidos cetoreductasa para la síntesis de compuestos quirales
|
DK3292136T3
(da)
|
2015-05-07 |
2021-03-22 |
Codexis Inc |
Penicillin-g-acylaser
|
US9683220B2
(en)
|
2015-07-07 |
2017-06-20 |
Codexis, Inc. |
P450-BM3 variants with improved activity
|
AU2017260355B2
(en)
|
2016-05-05 |
2023-03-30 |
Codexis, Inc. |
Penicillin-G acylases
|
IL263448B2
(en)
|
2016-06-09 |
2023-10-01 |
Codexis Inc |
Biological catalysts and methods for hydroxylation of chemical compounds
|
BR112018075932A2
(pt)
|
2016-06-15 |
2019-10-01 |
Codexis Inc |
variante de beta-glicosidase de ocorrência não natural, polinucleotídeo recombinante, vetor, célula hospedeira, métodos para produção de pelo menos uma variante de beta-glicosidade de ocorrência não natural, para conversão de um substrato aceptor de grupo glicosila em um produto beta-glicosilado e para transglicosilação de um substrato, e, composição.
|
WO2018038906A1
(en)
|
2016-08-26 |
2018-03-01 |
Codexis, Inc. |
Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
|
EP3565893A4
(en)
|
2017-01-05 |
2020-12-09 |
Codexis, Inc. |
PENICILLIN G ACYLASES
|
TWI797103B
(zh)
|
2017-02-03 |
2023-04-01 |
美商克迪科思股份有限公司 |
經工程處理之醣基轉移酶及甜菊糖之葡萄糖苷化方法
|
NZ755628A
(en)
|
2017-02-13 |
2023-09-29 |
Codexis Inc |
Engineered phenylalanine ammonia lyase polypeptides
|
CN110753684A
(zh)
|
2017-04-24 |
2020-02-04 |
特沙诺有限公司 |
尼拉帕利的制造方法
|
JP7045725B2
(ja)
|
2017-04-27 |
2022-04-01 |
コデクシス, インコーポレイテッド |
ケトレダクターゼポリペプチドおよびポリヌクレオチド
|
CA3062550A1
(en)
|
2017-05-08 |
2018-11-15 |
Codexis, Inc. |
Engineered ligase variants
|
WO2018231462A1
(en)
|
2017-06-14 |
2018-12-20 |
Codexis, Inc. |
Engineered transaminase polypeptides for industrial biocatalysis
|
EP3645713A4
(en)
|
2017-06-27 |
2021-06-30 |
Codexis, Inc. |
PENICILLIN G ACYLASES
|
AU2018292104A1
(en)
|
2017-06-30 |
2019-12-19 |
Codexis, Inc. |
T7 RNA polymerase variants
|
AU2018292105A1
(en)
|
2017-06-30 |
2019-12-19 |
Codexis, Inc. |
T7 RNA polymerase variants
|
JP2021502068A
(ja)
|
2017-11-07 |
2021-01-28 |
コデクシス, インコーポレイテッド |
トランスグルタミナーゼバリアント
|
WO2019116311A1
(en)
|
2017-12-13 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Carboxyesterase biocatalysts
|
AU2018383752A1
(en)
|
2017-12-13 |
2020-05-21 |
Codexis, Inc. |
Carboxyesterase polypeptides for amide coupling
|
WO2019241132A1
(en)
|
2018-06-12 |
2019-12-19 |
Codexis, Inc. |
Engineered tyrosine ammonia lyase
|
EP3820502A4
(en)
|
2018-07-09 |
2022-07-20 |
Codexis, Inc. |
MODIFIED PURINE NUCLEOSIDE PHOSPHORYLASE ENZYME VARIANT
|
SG11202012136YA
(en)
|
2018-07-09 |
2021-01-28 |
Codexis Inc |
Engineered pantothenate kinase variant enzymes
|
KR20210032417A
(ko)
|
2018-07-09 |
2021-03-24 |
코덱시스, 인코포레이티드 |
조작된 데옥시리보스-포스페이트 알돌라아제
|
US11034948B2
(en)
|
2018-07-09 |
2021-06-15 |
Codexis, Inc. |
Engineered phosphopentomutase variant enzymes
|
US11466259B2
(en)
|
2018-07-09 |
2022-10-11 |
Codexis, Inc. |
Engineered galactose oxidase variant enzymes
|
CA3105916A1
(en)
|
2018-07-12 |
2020-01-16 |
Codexis, Inc. |
Engineered phenylalanine ammonia lyase polypeptides
|
JP2021532757A
(ja)
|
2018-07-30 |
2021-12-02 |
コデクシス, インコーポレイテッド |
操作されたグリコシルトランスフェラーゼおよびステビオールグリコシドのグルコシル化方法
|
US11060075B2
(en)
|
2018-10-29 |
2021-07-13 |
Codexis, Inc. |
Engineered DNA polymerase variants
|
WO2020123286A1
(en)
|
2018-12-14 |
2020-06-18 |
Codexis, Inc. |
Engineered tyrosine ammonia lyase
|
US11427813B2
(en)
|
2018-12-20 |
2022-08-30 |
Codexis, Inc. |
Human alpha-galactosidase variants
|
US20230173066A1
(en)
|
2019-07-23 |
2023-06-08 |
Frieslandcampina Nederland B.V. |
Nutritional composition comprising milk fat and immunoglobulin
|
MX2022004017A
(es)
|
2019-10-02 |
2022-05-02 |
Abbott Diabetes Care Inc |
Deteccion de analitos por medio de interruptores de proteinas.
|
WO2021207200A2
(en)
|
2020-04-10 |
2021-10-14 |
Codexis, Inc. |
Engineered transaminase polypeptides
|
AU2021331493A1
(en)
|
2020-08-28 |
2023-03-09 |
Codexis, Inc. |
Engineered amylase variants
|
WO2022047262A1
(en)
|
2020-08-28 |
2022-03-03 |
Codexis, Inc. |
Engineered protease variants
|
US20220186231A1
(en)
|
2020-12-11 |
2022-06-16 |
Willow Biosciences, Inc. |
Recombinant acyl activating enzyme (aae) genes for enhanced biosynthesis of cannabinoids and cannabinoid precursors
|
JP2024500102A
(ja)
|
2020-12-18 |
2024-01-04 |
コデクシス, インコーポレイテッド |
操作されたウリジンホスホリラーゼ改変体酵素
|
CN117120599A
(zh)
|
2021-04-02 |
2023-11-24 |
科德克希思公司 |
工程化鸟苷酸激酶变体酶
|
US20220325285A1
(en)
|
2021-04-02 |
2022-10-13 |
Codexis, Inc. |
ENGINEERED CYCLIC GMP-AMP SYNTHASE (cGAS) VARIANT ENZYMES
|
CA3214972A1
(en)
|
2021-04-02 |
2022-10-06 |
Codexis, Inc. |
Engineered adenylate kinase variant enzymes
|
EP4314261A1
(en)
|
2021-04-02 |
2024-02-07 |
Codexis, Inc. |
Engineered acetate kinase variant enzymes
|
WO2023010083A2
(en)
|
2021-07-30 |
2023-02-02 |
Willow Biosciences, Inc. |
Recombinant prenyltransferase polypeptides engineered for enhanced biosynthesis of cannabinoids
|
CA3227236A1
(en)
|
2021-08-19 |
2023-02-23 |
Trish Choudhary |
Recombinant olivetolic acid cyclase polypeptides engineered for enhanced biosynthesis of cannabinoids
|
WO2023069921A1
(en)
|
2021-10-19 |
2023-04-27 |
Epimeron Usa, Inc. |
Recombinant thca synthase polypeptides engineered for enhanced biosynthesis of cannabinoids
|
WO2024040020A1
(en)
|
2022-08-15 |
2024-02-22 |
Absci Corporation |
Quantitative affinity activity specific cell enrichment
|